Carregant...
Next-generation cell therapies: the emerging role of CAR-NK cells
T cells engineered with chimeric antigen receptors (CARs) have revolutionized the field of cell therapy and changed the paradigm of treatment for many patients with relapsed or refractory B-cell malignancies. Despite this progress, there are limitations to CAR-T cell therapy in both the autologous a...
Guardat en:
| Publicat a: | Blood Adv |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Hematology
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7686910/ https://ncbi.nlm.nih.gov/pubmed/33232480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002547 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|